 - Impairment of gastrointestinal function or gastrointestinal disease that may significantly alter the absorption of sirolimus e.g. ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome or small bowel resection. A nasogastric tube NG tube is allowed. 